Self-Determined Learning Model of Instruction (SDLMI) for Autism Spectrum Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Autism Spectrum Disorder+4 More
Self-Determined Learning Model of Instruction (SDLMI) - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

This trial will compare the effectiveness of each intervention with and without the addition of our implementation strategy, UNITED. UNITED is a remote delivery of professional development modules specific to the intervention and active coaching as dictated by the intervention procedures.

Eligible Conditions
  • Autism Spectrum Disorder
  • Autism Spectrum Disorders
  • Neurodevelopmental Disorders

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Autism Spectrum Disorder

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: baseline, 12 months, and 18 months

Month 18
Social Network Survey
Week 24
Goal Attainment Scaling (GAS)
Self-Determination Inventory (SDI-SR)
Week 24
School Implementation Climate Scale
Month 18
Stages of Implementation Completion (SIC)

Trial Safety

Safety Progress

1 of 3

Other trials for Autism Spectrum Disorder

Trial Design

2 Treatment Groups

Implementation as Usual (IAU)
1 of 2
UNITED
1 of 2
Active Control
Experimental Treatment

358 Total Participants · 2 Treatment Groups

Primary Treatment: Self-Determined Learning Model of Instruction (SDLMI) · No Placebo Group · N/A

UNITED
Behavioral
Experimental Group · 1 Intervention: Self-Determined Learning Model of Instruction (SDLMI) · Intervention Types: Behavioral
Implementation as Usual (IAU)
Behavioral
ActiveComparator Group · 1 Intervention: Self-Determined Learning Model of Instruction (SDLMI) · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, 12 months, and 18 months

Who is running the clinical trial?

University of KansasOTHER
134 Previous Clinical Trials
322,935 Total Patients Enrolled
4 Trials studying Autism Spectrum Disorder
732 Patients Enrolled for Autism Spectrum Disorder
Health Resources and Services Administration (HRSA)Lead Sponsor
80 Previous Clinical Trials
111,914 Total Patients Enrolled
11 Trials studying Autism Spectrum Disorder
1,890 Patients Enrolled for Autism Spectrum Disorder
Drexel UniversityOTHER
133 Previous Clinical Trials
41,871 Total Patients Enrolled
8 Trials studying Autism Spectrum Disorder
22,064 Patients Enrolled for Autism Spectrum Disorder
University of PennsylvaniaOTHER
1,816 Previous Clinical Trials
41,114,735 Total Patients Enrolled
13 Trials studying Autism Spectrum Disorder
3,557 Patients Enrolled for Autism Spectrum Disorder
University of WashingtonOTHER
1,583 Previous Clinical Trials
1,565,628 Total Patients Enrolled
13 Trials studying Autism Spectrum Disorder
3,474 Patients Enrolled for Autism Spectrum Disorder
University of RochesterOTHER
787 Previous Clinical Trials
500,279 Total Patients Enrolled
11 Trials studying Autism Spectrum Disorder
9,235 Patients Enrolled for Autism Spectrum Disorder
University of California, DavisOTHER
837 Previous Clinical Trials
5,002,518 Total Patients Enrolled
14 Trials studying Autism Spectrum Disorder
6,970 Patients Enrolled for Autism Spectrum Disorder

Eligibility Criteria

Age Any Age · All Participants · 6 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
likely to result from study of genetic data A study of genetic data is likely to result in an expert medical diagnosis or educational classification of ASD.
in intervention We are looking for a parent or caregiver who is willing to participate in our intervention study
You are attending a Title I school or a rural school.
The family income is below 250% of the poverty guideline.
School staff who work with adolescents who have ASD or NDD often need to find different ways to manage behavior and communication.
63 adolescents with ASD or NDD who come from families with limited resources.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 21st, 2021

Last Reviewed: October 11th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

What state do they live in?
Pennsylvania50.0%
Texas25.0%
New York25.0%
How old are they?
< 1850.0%
18 - 6550.0%
What portion of applicants met pre-screening criteria?
Met criteria50.0%
Did not meet criteria50.0%
What site did they apply to?
University of Kansas100.0%